Chang‐Ying Guo

963 citations
23 papers · 769 indexed · h-index 10
Topics
Effects of Radiation Exposure (5 papers)Cancer Immunotherapy and Biomarkers (4 papers)Esophageal Cancer Research and Treatment (4 papers)
Partner nations
ChinaJapanPhilippines

In The Last Decade

Chang‐Ying Guo

21 papers receiving 760 citations

Peers

Chang‐Ying Guo
Comparison fields: 5 of 84
  • Molecular Biology 527
  • Cancer Research 396
  • Oncology 155
  • Epidemiology 108
  • Pulmonary and Respiratory Medicine 79
Replace Hyo Won Chang with:
Hyo Won Chang South Korea
Luis J. Schwarz Peru
Chaoju Gong China
Feifei Cheng China
Shan Pan China
Masafumi Kumano Japan
Agnete S. T. Engelsen Norway
Byung-Kyu Ryu South Korea
Melissa M. Wolf United States
Adam R. Wolfe United States
Chang‐Ying Guo relative to Hyo Won Chang South Korea Hyo Won Chang's profile →
Citations per field
00.5×1.5×
Hyo Won Chang · 1×
Citations per year

Countries citing papers authored by Chang‐Ying Guo

Since Specialization
Citations

This map shows the geographic impact of Chang‐Ying Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang‐Ying Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang‐Ying Guo more than expected).

Fields of papers citing papers by Chang‐Ying Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chang‐Ying Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang‐Ying Guo. The network helps show where Chang‐Ying Guo may publish in the future.

Co-authorship network of co-authors of Chang‐Ying Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Chang‐Ying Guo. A scholar is included among the top collaborators of Chang‐Ying Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chang‐Ying Guo. Chang‐Ying Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 0
3 3
4 4
5 6
6 16
7 4
8 24
9 9
10 61
11 6
12 7
13 16
14 135
15 8
16 19
17 26
18 24
19 12
20 370

About Chang‐Ying Guo

Chang‐Ying Guo is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 23 papers that have together received 769 indexed citations. Recurring topics across this work include Effects of Radiation Exposure (5 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Esophageal Cancer Research and Treatment (4 papers). The work is most often cited by research in Cancer Research (396 citations), Molecular Biology (527 citations) and Oncology (155 citations). Chang‐Ying Guo has collaborated with scholars based in China, Japan and Philippines. Frequent co-authors include Judy Lieberman, Leonora Balaj, Minh T. N. Le, Péter Hamar, Emre Basar, Tao‐Sheng Li, Shinji Goto, Yoshishige Urata, Lan Luo and Yan Chen. Their work appears in journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026